AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 52 filers reported holding AN2 THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,343,504 | -33.8% | 1,555,118 | 0.0% | 0.35% | -13.0% |
Q1 2024 | $5,054,134 | -90.8% | 1,555,118 | -41.9% | 0.40% | -93.4% |
Q4 2023 | $54,876,502 | +27.4% | 2,678,209 | 0.0% | 6.09% | -4.0% |
Q3 2023 | $43,065,600 | +293.0% | 2,678,209 | +107.7% | 6.34% | +252.9% |
Q2 2023 | $10,959,220 | – | 1,289,320 | – | 1.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 2,678,209 | $43,065,600 | 6.34% |
Octagon Capital Advisors LP | 867,575 | $13,950,606 | 2.14% |
RA Capital Management | 5,551,295 | $89,264,824 | 1.76% |
Frazier Life Sciences Management, L.P. | 1,388,889 | $22,333,335 | 1.48% |
Avidity Partners Management LP | 1,089,400 | $17,517,552 | 0.70% |
BVF INC/IL | 1,563,963 | $25,148,525 | 0.68% |
Monashee Investment Management LLC | 99,495 | $1,599,880 | 0.67% |
Nantahala Capital Management | 356,789 | $5,737,167 | 0.49% |
ACUTA CAPITAL PARTNERS, LLC | 13,300 | $213,864 | 0.14% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 905,556 | $14,561,340 | 0.03% |